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Phosphate steering by Flap Endonuclease 1
promotes 50-ﬂap speciﬁcity and incision to prevent
genome instability
Susan E. Tsutakawa1,*, Mark J. Thompson2,*, Andrew S. Arvai3,*, Alexander J. Neil4,*, Steven J. Shaw2,
Sana I. Algasaier2, Jane C. Kim4, L. David Finger2, Emma Jardine2, Victoria J.B. Gotham2, Altaf H. Sarker5,
Mai Z. Her1, Fahad Rashid6, Samir M. Hamdan6, Sergei M. Mirkin4, Jane A. Grasby2 & John A. Tainer1,7
DNA replication and repair enzyme Flap Endonuclease 1 (FEN1) is vital for genome integrity,
and FEN1 mutations arise in multiple cancers. FEN1 precisely cleaves single-stranded (ss)
50-ﬂaps one nucleotide into duplex (ds) DNA. Yet, how FEN1 selects for but does not incise
the ss 50-ﬂap was enigmatic. Here we combine crystallographic, biochemical and genetic
analyses to show that two dsDNA binding sites set the 50polarity and to reveal unexpected
control of the DNA phosphodiester backbone by electrostatic interactions. Via ‘phosphate
steering’, basic residues energetically steer an inverted ss 50-ﬂap through a gateway over
FEN1’s active site and shift dsDNA for catalysis. Mutations of these residues cause
an 18,000-fold reduction in catalytic rate in vitro and large-scale trinucleotide (GAA)n
repeat expansions in vivo, implying failed phosphate-steering promotes an unanticipated
lagging-strand template-switch mechanism during replication. Thus, phosphate steering is an
unappreciated FEN1 function that enforces 50-ﬂap speciﬁcity and catalysis, preventing
genomic instability.
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T
he structure-speciﬁc nuclease, ﬂap endonuclease-1 (FEN1)
plays a vital role in maintaining genome integrity by
precisely processing intermediates of Okazaki fragment
maturation, long-patch excision repair, telomere maintenance,
and stalled replication forks. During DNA replication and repair,
strand displacement synthesis produces single-stranded (ss)
50-ﬂaps, at junctions in double-stranded (ds) DNA. During
replication in humans, FEN1 removes B50 million Okazaki
fragment 50-ﬂaps with remarkable efﬁciency and selectivity to
maintain genome integrity1–3. Consequently, FEN1 deletion is
embryonically lethal in mammals4, and functional mutations can
lead to cancer5. FEN1 also safeguards against DNA instability
responsible for trinucleotide repeat expansion diseases6. As FEN1
is overexpressed in many cancer types7,8, it is an oncological
therapy target9,10.
Precise FEN1 incision site selection is central to DNA
replication ﬁdelity and repair. FEN1 preferentially binds to
double ﬂap substrates with a one nt 30-ﬂap and any length of
50-ﬂap, including zero. It catalyses a single hydrolytic incision one
nucleotide (nt) into dsDNA (Fig. 1a) to yield nicked DNA ready
for direct ligation11,12. Thus, FEN1 acts on dsDNA as both an
endonuclease (with 50-ﬂap) and an exonuclease (without 50-ﬂap).
Recent single molecule experiments show that FEN1 binds both
ideal and non-ideal substrates but decisively incises only its true
substrate13. In contrast to homologs in bacteriophage14–16 and
some eubacteria17, eukaryotic FEN1s do not hydrolyse within
50-ﬂap ssDNA.
However, key features of FEN1 substrate selection remain
unclear. FEN1 must efﬁciently remove 50-ﬂaps at discontinuous
ss-dsDNA junctions yet avoid genome-threatening action on
continuous ss–ds junctions, such as ss gaps or Holliday junctions.
Paradoxically, other FEN1 50-nuclease superfamily members3 are
speciﬁc for continuous DNA junctions: namely, ERCC5/XPG
(nucleotide excision repair), which acts on continuous ss-ds
bubble-like structures; and GEN1 (Holliday junction resolution),
which processes four-way junctions. Structures determined with
DNA of eukaryotic superfamily members lack ss-ds junction
substrate with 50-ssDNA or the attacking water molecule leaving
cardinal questions unanswered18–22. For example, structures of
FEN1 and Exo1 go from substrate duplex DNA with the scissile
phosphodiester far from the catalytic metals to an unpaired
terminal nt in the product; is the unpairing occurring before or
after incision?
Models of FEN1 speciﬁcity must address how ss–ds junctions
are recognized and how 50-ﬂaps, as opposed to continuous
ssDNA are recognized. There are threading and kinking models.
To exclude continuous DNAs, 50-ﬂaps may thread through a
‘tunnel’21,23–25 formed by two superfamily-conserved helices
ﬂanking the active site, known as the ‘helical gateway,’ topped
by a ‘helical cap’ (Fig. 1b). Due to cap and gateway disorder in
DNA-free FEN1, they are thought disordered during threading
and to undergo a disorder-to-order transition on 30-ﬂap
binding21,24,26. In this threading model, however, ssDNA passes
through a tunnel without an energy source and directly over the
active site, risking non-speciﬁc incision. These issues prompted
an alternative clamping model where the ss ﬂap kinks away from
the active site11,20 (Fig. 1b). Whereas these models explain
selection against continuous DNA junctions, FEN1 exonuclease
activity does not require a 50-ﬂap. Furthermore, how FEN1
prevents off target incisions and moves the dsDNA junction onto
the metal ions are not explained by these models.
Here crystallographic analyses uncover an unprecedented
electrostatic steering of an inverted 50-ﬂap through the human
FEN1 (hFEN1) helical gateway. Gateway and cap positively-
charged side chains are positioned to ‘steer’ the phosphodiester
backbone across the active site, energetically promoting threading
and preventing nonspeciﬁc hydrolysis within the 50-ﬂap.
Mutational analysis of these positively charged ‘steering’ residues
revealed an added role of phosphate steering in moving
dsDNA towards the catalytic metal ions for reaction.
Moreover, phosphate steering mutations efﬁciently blocked
Rad27 (S. cerevisae homolog of hFEN1) function, causing
a compromised response to DNA damaging agents and
dramatically increased expandable repeat instability.
Results
FEN1 selects for 50-ﬂaps by steering ﬂap through a gateway. To
obtain structures of hFEN1 with a ss 50-ﬂap substrate for insight
into ss 50-ﬂap selection, we crystallized three hFEN1 active site
mutants D86N, R100A and D233N with a double-ﬂap (DF)
substrate and with Sm3þ (Fig. 1 and Supplementary Figs 1
and 2A)27. Mg2þ is the physiological cofactor. D86N, R100A and
D233N mutations slow the hFEN1 catalysed reaction rate by
factors of 530, 7,900 and 16 respectively (Supplementary Fig. 2B).
The DF substrates in the crystal structures had a ss 50-ﬂap
(4–5 nt) and a 1 nt 30-ﬂap, termed S4,1 or S5,1 (Supplementary
Fig. 1). The DNA-enzyme complex structures for hFEN1-D86N,
hFEN1-R100A, and hFEN1-D233N were determined to 2.8, 2.65,
and 2.1 Å resolution, respectively (Figs 1c,d and 2, Supplementary
Fig. 2 and Table 1). In all cases, the overall protein resembled
wild-type (wt) hFEN1 (with product DNA, PDB code 3Q8K)21,
with root mean square deviation (RMSD) values of 0.26
for hFEN1-R100A, 0.22 for hFEN1-D233N, and 0.42 for
hFEN1-D86N.
These structures show that FEN1 interacts primarily (88% by
PISA interface analysis28) with two regions of B100 bent
dsDNA supporting prior observations21, rather than to the ss
50-ﬂap in these structures (Figs 1c,d and 2, Supplementary
Movie 2). FEN1 binding to dsDNA is mediated by four regions:
(1) a hydrophobic wedge (composed of helix 2 and helix
2–3 loop) and b pin (formed between b strands 8 and 9)
sandwich upstream and downstream dsDNA portions at the
bending point of the two-way junction with Tyr40 packing at
the ss/dsDNA junction; (2) a C-terminal helix-hairpin-helix
motif binds upstream dsDNA and the one nt 30-ﬂap and is
absent from superfamily-related members hEXO1 (ref. 20) and
bacteriophage 50-nuclease structures29; (3) the helix-2turn-helix
(H2TH) motif with bound Kþ ion and positive side chains bind
downstream dsDNA; and (4) the two-metal ion active site near
the 50-ﬂap strand. Much of the interaction (43% by PISA analysis)
is to the strand complementary to the ﬂap strands, reinforcing
dsDNA speciﬁcity.
The dsDNA binding sites on either side of the active site,
the Kþ and the hydrophobic wedge, are spaced one helical turn
apart (Supplementary Movie 2). Their spacing enforces the
speciﬁcity for helical dsDNA and places the 50-ﬂap in the active
site, selecting against unstructured ssDNA or 30-ﬂaps that would
require a narrower spacing. Additionally, the minor-groove
phosphate backbone is recognized by superfamily-conserved
Arg70 and Arg192 pair spaced 14Å apart (Fig. 2, Supplementary
Movie 1). Unique to FEN1, cap positive side chains (Lys125,
Lys128, Arg129) interact with the template strand at the
ss/dsDNA junction (Supplementary Fig. 3, Supplementary
Movie 1). Lys128 and Arg47 pack against each other, linking
the 30-ﬂap pocket to the gateway helices. The active site consists
of seven superfamily-conserved metal-coordinating carboxylate
residues plus invariant Lys93 and Arg100 from gateway helix 4
and Gly2 at the processed N-terminus (Figs 2 and 3c,
Supplementary Movie 4). An ordered gateway and cap formed
by helices 2, 4 and 5 are observed above the active site in these
three structures. Helix 2 Tyr40 forms part of the hydrophobic
wedge and packs against the duplex DNA at the bend.
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In the hFEN1-D86N and hFEN1-R100A structures, the ssDNA
(50-ﬂap) region of the substrate threaded through the tunnel
formed by the gateway/cap (Figs 1d and 2a, and Supplementary
Fig. 2A and Supplementary Movie 1). This observation explains
how FEN1 excludes continuous DNA like Holliday junctions and
DNA bubbles. The third independent hFEN1-D233N crystal
structure captures two cleaved nts from the 50-ﬂap bound on the
other side of the tunnel from the dsDNA, consistent with
threading (Fig. 3a and Supplementary Fig. 2A). Together, these
three distinct structures support the threading model to validate
substrates have a ss 50-ﬂap.
Phosphate steering inverts the ss phosphodiester backbone. In
both threaded substrate structures, the ss 50-ﬂap phosphodiester
backbone is ‘inverted’ between the þ 1 and þ 2 positions,
with the þ 2 and þ 3 phosphates facing away from the active
site metals and the DNA bases facing the metals (Fig. 1b,d
and Supplementary Movie 1). (We denote the plus and minus
positions relative to the scissile phosphate). This inversion would
place the ﬂap phosphodiesters away from the catalytic metals and
thereby logically reduce inadvertent incision within the ssDNA.
In both structures, the inverted þ 1 phosphodiester is directly
between the gateway helices with the bases on either side of the
5’ flap substrate
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Figure 1 | Speciﬁcity and inverted threading of ss50-ﬂap in hFEN1 D86N substrate structure. (a) Schematic FEN1 incision on an optimal double-ﬂap
substrate, incising 1 nt into dsDNA to ensure a ligatable product. (b) Proposed models for ssDNA selection. (c) Top view of hFEN1-D86N crystal structure
showing extensive interaction to dsDNA arms of 5’ ﬂap substrate. The 5’-ﬂap substrate is composed of three strands; the 50-ﬂap strand (orange), the
template strand (brown), and the 30-ﬂap strand (pink). Functionally critical regions in FEN1 include the gateway (blue) and the cap (violet) for selecting
substrates with ss-50-ﬂaps, the hydrophobic wedge between the 30-ﬂap binding site and the gateway/cap (dark green), the Kþ ion and H2TH (purple) that
interacts with the downstream DNA, the beta pin (grey) that locks in the DNA at the bend. Relative DNA orientation shown in schematic on lower right. (d)
Front and side views of hFEN1-D86N crystal structure showing helical gateway and cap architecture position positively-charged residues to steer ss 50-ﬂaps
through a protecting gateway in an inverted orientation across the active site. Relative DNA orientation is shown in schematic. The inverted 50-ﬂap ssDNA
is threaded between gateway helices (blue) and under the helical cap (violet). The inverted threading reveals charged interactions to basic sidechains in the
cap and van der Waals interactions to ssDNA. See also Supplementary Figs 1–3; Table 1, and Supplementary Movies 1 and 2.
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gateway. In the hFEN1-D86N structure, two basic residues of the
gateway/cap, Arg104 and Lys132, were within 4–7Å of the þ 1,
þ 2 and þ 3 phosphodiester. These residues are positioned to
energetically promote threading and an inverted orientation.
They are conserved in FEN1 and semi-conserved across the
50-nuclease superfamily and shown important for incision activity
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Figure 2 | FEN1 superfamily sequence and secondary structure alignment. Map of FEN1 secondary structure (PDB code 3q8k), structural elements,
and mutants to a sequence alignment of FEN superfamily human members. XPG residues 117–766 were removed (dash) to facilitate alignment.
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(Fig. 2 and Supplementary Fig. 3)3,21,30. The þ 2 and þ 3 nt of
the 50-ﬂap were sandwiched between the main chain (residues
86–89 and residues 132–135) on one side of the channel and
Leu97 on the other (Supplementary Fig. 2C) by non-sequence
speciﬁc van der Waals contacts. The overall inverted ﬂap orientation
resembles the hFEN1-R100A structure with the þ 1 phosphate
remaining within 7Å of Arg104, but shifted towards Arg103,
presumably due to Arg100 removal. Together, these substrate
structures suggest that basic residues enable a phosphate
steering mechanism, which we here deﬁne as electrostatic
interactions that can dynamically position the phosphodiester
backbone.
Shifting of the scissile phosphate and the catalytic mechanism.
In the hFEN1-D86N structure, we were surprised that the
scissile phosphate was within catalytic distance of the active site
while surrounding bases remained basepaired to the template
strand (Fig. 3). This contradicts the prevailing hypothesis
that surrounding bases must unpair for the scissile phosphate to
move into the active site for incision3. Similarities and
functionally-signiﬁcant differences appeared on closer
examination of hFEN1-D86N, hFEN1-R100A, and an earlier
structure of FEN1-substrate with no 50-ﬂap or þ 1 phosphate
(PDB code 3Q8L). In all three substrate structures, the dsDNA
major groove is widened as it approaches the active site, and
DNA bases ﬂanking the scissile phosphate are stacked with one
another, with the þ 1 base packed against Tyr40. However, the
basepairing, the scissile phosphodiester bond location and the
Tyr40 rotamer are distinctly different in the respective complexes,
despite containing the same dsDNA sequence. In the 3Q8L
structure, the DNA remained fully basepaired, and the scissile
phosphodiester was positionedB6Å away from catalytic metals.
In the hFEN1-R100A structure, the scissile phosphodiester bond
wasB4–5Å away from the metal ions, although  1 and þ 1 nts
have moved towards the active site and away from the template
strand. The  1 and  2 nts display less base overlap (stacking),
and the þ 1 and  1 nts are no longer hydrogen bonded to the
template strand (4–6Å apart).
In striking contrast, the scissile phosphodiester bond was
directly coordinated to the one active site metal ion in the
hFEN1-D86N structure (Fig. 3c). Furthermore, the þ 1 and
 1 nts remained unexpectedly basepaired to the template strand,
which is shifted relative to the other substrate structures via
a dsDNA distortion surrounding the scissile phosphodiester
(Fig. 3b and Supplementary Fig. 2D,E). There is no base stacking
between  1 and  2 nts in the 50-ﬂap strand; instead, an unusual
interstrand base stacking interaction occurs between the  2 nt of
the 50-ﬂap strand and the template strand opposite of the  1 nt.
We had hypothesized that unpairing of the þ 1 and  1 was
required to move the scissile phosphate to within catalytic
distance of the active site metals3,21,31,32. This new hFEN1-D86N
substrate structure shows instead that basic residues can rotate
dsDNA into the active site with basepairing intact (Fig. 3,
Supplementary Movie 3). Moreover, since the DNA in 3Q8L,
which was the furthest from the active site, lacked a 50-ﬂap or þ 1
phosphate, the DNA movements observed in the hFEN1-R100A
and hFEN1-D86N structures are likely partly a consequence of
either the 50-ﬂap and/or the þ 1 phosphate.
In concert with the DNA rotation in hFEN1-D86N, Tyr40 is in
a different rotamer conformation from all other substrate or
product bound or DNA-free hFEN1 structures (Fig. 3a,b and
Supplementary Movie 3)21,26. This Tyr40 rotamer shift tracks
duplex DNA rotation into the active site. The Tyr ring is fully
stacked on the þ 1 base, and its side chain hydroxyl forms a
hydrogen bond to the þ 1 phosphate. Notably, as duplex DNA is
not shifted close to the catalytic metal in the R100A structure, this
structure may represent a pre-reactive substrate form. Its Tyr40
stacks at a 50 angle with the þ 1 nt and resembles the other
hFEN1 structures, suggesting that the Tyr40 rotamer is linked
Table 1 | X-ray data collection and reﬁnement statistics (molecular replacement).
hFEN1-D86N hFEN1-R100A hFEN1-D233N
Data collection
Space group P 31 2 1 P 31 2 1 P 31 2 1
Cell dimensions
a, b, c (Å) 105.8 105.8 100.7 105.2 105.25 104.1 105.2 105.2 104.5
a, b, g () 90 90 120 90 90 120 90 90 120
Resolution (Å) 18.2–2.8 (2.9–2.8) 37.0–2.6 (2.7–2.6) 34.5–2.1 (2.2–2.1)
Rmeas 0.08 (1.0) 0.07 (0.70) 0.09 (0.65)
I/sI 22.7 (1.95) 12.7 (2.9) 73.9 (5.00)
Completeness (%) 1.00 0.98 0.99
Redundancy 8.6 (8.5) 5.2 (5.4) 13.8 (10.4)
Reﬁnement
Resolution (Å) 18.2–2.8 37.0–2.6 34.5–2.1
No. reﬂections 30,758 (3,031) 34,943 (4,282) 39,092 (3,705)
Rwork/Rfree 0.21/0.26 0.22/0.25 0.18/0.22
No. heavy atoms 3,534 3,703 4,183
Protein/DNA 3,492 3,519 3,545
Sm3þ , Kþ 7 6 9
Water 36 173 625
B-factors 91 64
Protein/DNA 113.97 92 63
Sm3þ , Kþ 144 91.5 93.3
Water 110 77.3 69
R.m.s. deviations
Bond lengths (Å) 0.004 0.005 0.003
Bond angles () 0.56 0.60 0.54
Related to Figs 1 and 3.
One crystal was used for each mutant. Values in parentheses are for highest-resolution shell.
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to shifting duplex DNA into a catalytic position. In the
hFEN1-D86N-substrate structure, cap and gateway helices 4
and 5 are shifted 1–3Å towards the dsDNA relative to all other
hFEN1 crystal structures with DNA (Fig. 3b and Supplementary
Movie 3). The backbone of helix 2 (which contains Tyr40) does
not change position.
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Figure 3 | Three FEN1 crystal structures show threading through the capped gateway. (a) DNA from hFEN1-D86N, hFEN1-R100A, and hFEN1-D233N
structures showed threading not clamping. Tyr40 (stick model) changes its rotamer to track DNA movement through the gateway in the hFEN1-D86N
structure. (b) A protein chain overlay between hFEN1-R100A (outline) and hFEN1-D86N (coloured) highlights how the helical gateway and cap and the
DNA rotate closer together in the hFEN1-D86N complex. See Supplementary Movie 3. (c) The hFEN1-D86N active site revealed a water molecule
positioned for linear attack on the scissile phosphate. Orthogonal views are shown. The 2nd metal position (outlined in black and denoted by Me*) is not
observed in the hFEN1-D86N and is shown by overlaying the protein from the wt-product structure (PDB code 3Q8K). See also Supplementary Figs 1–4,
and Supplementary Movie 4. (d) Protein chain overlay of hFEN1-D86N-substrate (coloured) and wt-product (outline, PDB code 3Q8K) structures shows
that the scissile phosphate is shifted in the active site B2Å (demarked by arrow).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms15855
6 NATURE COMMUNICATIONS | 8:15855 | DOI: 10.1038/ncomms15855 | www.nature.com/naturecommunications
Close examination of the hFEN1-D86N structure revealed a
water molecule 3.3 Å from the scissile phosphate (Fig. 3c,
Supplementary Fig. 4, and Supplementary Movie 4). This water
is positioned for a linear attack on the scissile phosphate and for
its evident activation by the catalytic metal and the Gly2 at the
FEN1 N terminus, which was proposed to replace the ‘third’
metal in bacteriophage FEN33. Asp233 is 3 Å from the attacking
water and contributes modestly to catalysis; the D233N mutant
has 16-fold reduced but still substantial catalytic activity
compared to mutants of other invariant carboxylates, such as
D181A21 and D86N (Supplementary Fig. 2B). When a second
metal ion is modeled by overlay with the hFEN1-product
structure (PDB code 3Q8K), the structure is reminiscent
of the classical two-metal-ion catalysis34. Moreover, superfamily
conserved and catalytically required21 Lys93 and Arg100
sidechains point towards the scissile phosphodiester bond,
poised to assist metal ion mediated hydrolysis. On the basis of
the hFEN1-R100A structure, Arg100 is also likely essential for
shifting of the scissile phosphate into direct contact with
the catalytic metals. Notably, the scissile phosphate has moved
B1–2Å between hFEN1-D86N-substrate and wt hFEN1-product
(Fig. 3d). An analogous metal movement into more optimal
coordination geometry in an RNaseH-product structure was
proposed to favour product formation35. We cannot exclude a
possible third metal ion as time-resolved experiments on other
enzymes show metals ions can appear and disappear during
reaction36–40.
Together these structures reinforce and extend biochemical
data that suggest that FEN1 checks for the ss 50-ﬂap by threading
it through a tunnel formed between the active site and capped
gateway helices (Fig. 1d)24,41. The substrate structures imply the
50-ﬂap is (1) electrostatically steered through the capped gateway
by conserved basic residues in the gateway and cap and (2)
positioned in an inverted orientation.
Biochemically testing phosphate steering. If the gateway/cap
region basic residues steer the phosphodiester backbone as
implied by the structures, then their mutation should affect
50-ﬂap substrate incision rates. On the basis of the hFEN1-R100A
structure, we mutated three basic residues (Arg103, Arg104 and
Lys132) positioned to guide the phosphodiester backbone and
stabilize the inverted ssDNA orientation (Fig. 1d). We also
mutated Arg129, which is adjacent the other residues and could
act in steering. When the helical cap is structured, Arg129 makes
a long-range electrostatic interaction with a phosphate of
the template strand21, a distance shortened in hFEN1-D86N by
template strand relocation. Strikingly, these four basic residues
are conserved across all FEN1s including yeast and archaeal,
except for the less-speciﬁc phage 50 nucleases (Supplementary
Fig. 3). As the helical gateway and cap regions are ﬂexible before
productive DNA binding22,24,26, speciﬁc interactions would seem
unlikely during the ﬂap threading process but electrostatic
guidance is possible. Notably, as these side chains range from
10 to 19Å from the target phosphate, they are unlikely to impact
FEN1 activity by aspects other than electrostatic guidance and
substrate-positioning. To test this idea, we mutated them to
alanine or glutamate to either remove the attractive positive
charge or provide a repulsive charge, respectively.
These charge mutations all reduced speciﬁc incision activity on
a 50-ﬂap substrate, S5,1 (Fig. 4a), indicating an important
functional role. Under multiple turnover conditions, single
mutations R103A and K132A moderately decreased the reaction
rate relative to wt hFEN1 by 3- and 5-fold, respectively, whereas a
20-fold decrease was observed with either R104A or R129A
(Fig. 4b and Supplementary Fig. 5A,B). These rate decreases
are consistent with a single residue electrostatic guidance
interaction42. Double mutant R104AK132A showed an additive
effect with 200-fold reduced activity and, signiﬁcantly,
the corresponding repulsive mutant R104EK132E was far
more severely compromised with a rate reduction of 11,000
compared to the wt enzyme. Importantly, the substrate
dissociation constant (Kd) for each of these double mutants was
only modestly raised (Supplementary Fig. 6). This suggests
deﬁcient substrate positioning, not poor binding, as the
major contributing factor to diminished activity. Similarly,
double mutants R103AR129A or R103ER129E showed
reductions in reactivity of 70- or 5,000-fold, respectively,
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without any substantial effect on Kd. Analogous trends in rate
effects were observed under single turnover kinetic conditions
(Supplementary Fig. 5C,D).
Mutating all four gateway/cap residues to glutamate
(‘QUAD-E’ mutant) severely impaired activity (18,000-fold
slower than wt FEN1). Strikingly, the Kd increased only 17-fold
showing the enzyme was folded and capable of substrate
binding. This large rate decrease is remarkable for mutation of
residues not acting in catalysis and distant from the active
site: it resembles the penalty for streptavidin added to
50-biotinylated substrates, which would prevent 5’-ﬂap gate-
way/cap threading24.
If the FEN1 basic cap residues are primarily required for ss
50-ﬂap steering, then their mutation should not be deleterious to
incision activity on an exonucleolytic substrate lacking a 50-ﬂap
but with a 50-phosphate (S0,1-5P; Fig. 4a). This substrate was
hydrolysed sevenfold more slowly than the DF S5,1 by wt hFEN1
(Fig. 4b and Supplementary Fig. 5A,B) showing that threading
the 50-ﬂap facilitates access to the catalytically competent
conformation, as well as being a key mechanism in substrate
selection. For reaction rates expressed relative to wt hFEN1 to
normalize for this sevenfold difference, the gateway mutants all
proved similarly defective on both the exonucleolytic (S0,1-5P)
and endonucleolytic (S5,1) substrates (relative rates given in
Supplementary Fig. 4B). These results unmask a key universal
role for þ 1 phosphate steering in the FEN1 incisions of
both exonucleolytic and endonucleolytic substrates (since this
phosphate is present in both substrates).
Given the results with the exonucleolytic substrate and the
observation that DNA movement towards the active site required
a þ 1 phosphate43, we reasoned that some basic residues were
electrostatically interacting with the þ 1 phosphodiester of
dsDNA to facilitate this movement44. To test this hypothesis,
we measured reaction rates with an analogous exonucleolytic
substrate lacking the 50-phosphate at the þ 1 position (S0,1-5OH;
Fig. 4a). This substrate was bound 20-fold more weakly and
incised 300-fold more slowly than S0,1-5P by wt hFEN1 (Fig. 4b,
Supplementary Figs 4 and 5). These data indicate that
50-phosphate (þ 1 phosphate) interactions stabilize the enzyme-
substrate complex and contribute to catalysis. Combined and
individual mutations of R103A and R129A all decreased incision
rates of S0,1-5OH analogously to the other substrates. However,
R104A, K132A and R104AK132A all processed S0,1-5OH at a
similar rate to wt hFEN1. These results imply that the þ 1
phosphate group functionally interacts with Arg104 and Lys132,
consistent with the phosphate steering hypothesis, but that
Arg103 and Arg129 (along with Arg100 and Lys93) have long-
range interactions to other parts of the DNA substrate, including
the scissile phosphate itself.
A role for phosphate steering in genome stability. To test
the biological importance of the basic cap and gateway residues,
we made equivalent mutations in the helical gateway/cap region
of Rad27, the S. cerevisiae homolog of hFEN1, to analyse their
role in genome integrity in vivo. Alanine or glutamate mutations
were introduced at Rad27 Arg104, Arg105, Arg127 and Lys130;
equivalent to hFEN1 Arg103, Arg104, Arg129 and Lys132,
respectively (Fig. 5a). Growth characteristics of double- or
quadruple-mutant yeast strains were compared to wild type
RAD27 (wt) strain and rad27-D179A (corresponding to human
D181A whose incision rate is given in Supplementary Fig. 2B), a
severely catalytically impaired mutant, which displays an
equivalent phenotype to the rad27 null strain (that is, sensitivity
to hydroxyurea, a replication inhibitor and DNA-damaging UV
light1,45).
Even without exogenous treatment, quadruple glutamate
mutant (Fig. 5a) showed growth inhibition resembling that for
the active site mutant rad27-D179A. Replication stress induced by
hydroxyurea greatly accentuated this effect. Moderate UV
irradiation (100 Jm 2) was strongly deleterious to both strains,
and higher-dose irradiation (200 Jm 2) further revealed UV
sensitivity for the double glutamate (2E-1; R105EK130E)
and quadruple alanine (4A) mutants (Fig. 5a). Thus, electrostatic
interactions of gateway/cap basic residues with DNA are critical
for ﬂap endonuclease biological function, with particular
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Figure 5 | Phenotypic and DNA repeat expansion defects of Rad27 basic
cap residue mutations in yeast S. cerevisiae. (a) Table of the tested basic
residues in yeast (and their human counterpart) and spot-test (serial
ﬁvefold dilutions) for yeast growth with and without exposure to
hydroxyurea (replication inhibitor) or UV light (DNA-damaging).
(b) Experimental system to measure the rates of large-scale repeat
expansions in yeast. The (GAA)100/(TTC)100 repeat is incorporated into
the intron of an artiﬁcially split URA3 gene. Addition of Z10 extra repeats
inhibits reporter’s splicing, which allows cells with repeat expansions to
grow on 5-FOA-containing media. (c) Effect of active site control and
phosphate steering mutations in the RAD27 gene on repeat expansion rates
(error bars represent 95% conﬁdence intervals of calculated expansion
rates). (d) Rad27 protein expression was not substantially altered in the
mutated strains. See also Supplementary Fig. 7 and Supplementary Table 1.
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deleterious effects on cells under replication stress and/or with
damaged DNA.
Rad27 inactivation in yeast stimulates expansion of trinucleo-
tide repeats relevant to human disease46–48. We therefore tested
the effect of phosphate steering mutations on expansion rates of
(GAA)n repeats using our system (Fig. 5b), which contains a
(GAA)100 tract situated in the intron of a Ura3 reporter gene49,50.
Addition of 10 or more repeats to the (GAA)100 tract effectively
blocks splicing, resulting in gene inactivation and rendering the
yeast resistant to 5-ﬂuoroorotic acid (5-FOA). The repeat
expansion rates in the rad27 knockout and in the severely
catalytically impaired D179A active site metal ligand mutant was
increased byB100-fold compared to wt (Fig. 5c,d). Strikingly for
a non-active site mutant, phosphate steering 4E mutant exhibited
a quantitatively similar phenotype. The double glutamate (2E-1,
2E-2) and 4A mutants showed intermediate (B10-fold) increases
in repeat expansion rates. These results match growth
characteristics of these mutants and emphasize the role of
electrostatic interactions of the gateway basic residues with DNA
in repeat-mediated genome instability.
Ligation of unprocessed 50-ﬂaps to the 30-end of the
approaching Okazaki fragment is proposed to cause the elevated
repeat expansions in Rad27 mutants48,51,52. In this scenario, one
expects added repeat lengths to be relatively short: less than the
size of an Okazaki fragment. In fact, the major mutations caused
by disruption of the RAD27 gene in yeast were repeat-related
expansions of 5–108 bases53. Recently, the median size of the
unprocessed 50-ﬂap in S. pombe FEN1 knockout was measured as
89 nts54. Given these numbers, the median expansion size of GAA
repeats in our experimental system should be B30 repeats in
Rad27 mutants.
To deﬁne the size distribution of expansion products, we
measured the scale of repeat expansions in wt and Rad27 mutants
described above via PCR (Fig. 6a). In the wt strain, median
expansion size corresponded to 47 triplets49. The rad27 knockout
was different: median expansion size was 32 repeats, and
Kolmogorov-Smirnov (KS) comparison conﬁrms a signiﬁcant
difference from the wt strain (Po0.001), which agrees with
known ﬂap size in FEN1 knockouts54. The expansion scale in
near-catalytic-dead (D179A) and 4E Rad27 mutants lies between
the wt and knockout mutant: the median is 40 repeats and KS
shows signiﬁcant difference from wt (Po0.05). Finally, the scale
of expansions in 2E and 4A mutants is greater than wt with
medians from 50 to 66 added repeats. Thus, the 100-fold increase
in expansions (Fig. 5c) in phosphate steering mutants cannot
be explained by an increase in small-scale expansions alone
(caused by simple 50-ﬂap ligation), but is a consequence of larger
expansions. Thus, most expansions in the Rad27 phosphate
steering mutants originate via mechanisms distinct from simple
50-ﬂap ligation (see Discussion). Overall, these Rad27 results
suggest that functional phosphate steering of 50-ﬂaps and dsDNA
is vital for genome integrity: in promoting normal growth,
in response to DNA damage, and in preventing trinucleotide
repeat expansions.
Discussion
We sought to understand the mechanism whereby FEN1s binds
and precisely incises ss-dsDNA junctions yet excludes hydrolysis
of continuous DNA substrates, reasoning that this speciﬁcity
was key to FEN1 functions during replication and repair.
These investigations resolve controversies and improve our
understanding of how FEN1-DNA interactions provide speciﬁcity
and genome stability.
First, elucidation of a 50-ﬂap DNA threaded through the helical
gateway/cap answers a longstanding question in eukaryotic FEN1
function and explains the selection of 50-ﬂap substrates with
free 50-termini. Although threading occurs in other enzymes,
phosphate steering and inverted threading are extraordinary. For
example, bacteriophage T5 50-nuclease threads substrates29, but
positions the 50 ﬂap primarily through hydrophobic interactions
to the 50 ﬂap nucleobases. The phosphodiester is closer to the
metals than the nucleobases, consistent with its lower incision site
speciﬁcity and tendency to cleave within the ssDNA 50-ﬂap. In
other enzymes, threading selects for free ss 50-termini that will
undergo incision and there is no inversion. However, FEN1
preserves, rather than degrades, the threaded nucleic acid.
Second, our results uncover an essential function in FEN1
speciﬁcity and catalysis for phosphate steering, which we
deﬁne as electrostatic interactions that dynamically control
the phosphodiester backbone. The parallel effects of steering
mutations on either endonucleolytic or exonucleolytic reactions
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Figure 6 | FEN1 phosphate steering is essential for lagging strand
precision at DNA repeats. (a) Graphed distributions of repeat expansion
lengths shows that the majority of expansions in the wt, phosphate steering
and D179A Rad27 mutants are 430 repeats. The numbers of added
repeats in each strain are shown as scatter plots alongside box-and-whisker
plots with 5 and 95% whiskers. The number of colonies tested are given in
the parentheses. (b) Two models for repeat expansions driven by the
presence of an unprocessed 50-ﬂap. In model 1 (left panel) the repeat on the
50-ﬂap ligates to the 30-end of the oncoming Okazaki fragment followed by
its equilibration into a loop. After the next round of replication, up toB30
repeats can be added (see text for details). In model 2 (right panel), the 50-
ﬂap folds back forming a triplex, which blocks Pol(d) DNA synthesis along
the lagging strand template and promotes its switch to the nascent leading
strand. This template switch mechanism explains the accumulation of
large-scale repeat expansions 430 repeats.
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(that is, on substrates with or without a 50-ﬂap) indicated
involvement of basic gateway/cap residues in a rate-limiting step
in the FEN1 catalytic pathway, that is, in moving the target
phosphodiester bond from the ss-ds junction onto catalytic metal
ions. Thus, phosphate steering may act in orienting the ss 50-ﬂap
during threading (negative design to avoid off-target reactions)
and moving the scissile phosphate into catalytic distance of the
metals (positive design to enhance target reactions) (Fig. 7a).
Notably, steering residue Arg104, is semiconserved throughout
the superfamily suggesting that phosphate positioning occurs in
other members.
Third, the proposed requirement for double base unpairing
for the dsDNA to reach the active site metal ions3 needs
re-evaluation. Our observation of basepaired DNA contacting an
active site metal ion with a water molecule positioned for in-line
attack, would generate the arrangement for ‘two-metal-ion’
catalysis. This basepaired catalytically competent conformation
appears at odds with spectroscopic characterization of FEN1 and
GEN1 substrate complexes19,32,44, and the inability of FEN1 to
process duplexes cross-linked at the terminal basepair31,55,
consistent with an unpairing mechanism. Yet, the DNA
distortion seen in structures here (Supplementary Fig. 2E)
provides an alternative explanation implying dsDNA can
remain basepaired and roll onto the active site metal ions aided
by Tyr40 rotation and by positive side chains on the helical
gateway and cap.
Whereas replication ﬁdelity is canonically based on sequence, it
furthermore depends on sequence-independent speciﬁcity in
FEN1. Importantly, structural elements critically involved in
FEN1 function, including phosphate steering and inverted
threading, require key residues distant from the active site metal
ions. Indeed, clinically relevant FEN1 mutations compiled by
The Cancer Genome Atlas (TCGA) and others5,56,57 map to these
structural elements (Fig. 7b). So, although tumour mutation data
has been called ‘a bewildering hodgepodge of genetic oddities’58,
for FEN1, there is a clear link of structurally-mapped mutations
to compromised function, genomic instability and cancer.
Although these mutations may retain nuclease activity, even
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tiny off target activity risks toxicity and genomic instability, and
replication mutations account for two-thirds of the mutations in
human cancers59.
We uncovered a role for phosphate steering in triplet (GAA)n
repeat expansions, that also implicates template switching from
the lagging strand due to FEN1 defects. Most expansions in
Rad27 phosphate steering mutants were large-scale (430 repeats;
Fig. 6a) which is difﬁcult to explain by the canonical ﬂap-ligation
model for repeat instability46,48,51,60. In this model, an
unprocessed 50-ﬂap is ligated to the 30-end of the approaching
Okazaki fragment (Fig. 6b, left), limiting the length of expansions
to the size of those ﬂaps. Recently, the median size of the 50-ﬂap
in a FEN1 knockout was found to be 89 nts54, that is,B30 triplet
repeats. Since median expansion size in phosphate steering
mutants is 430 repeats, we propose that besides a ﬂap-ligation
model, a template switch between nascent repetitive strands
occurs as a replication fork stumbles through the repeat
sequence50 (Fig. 6b, right). Unprocessed (TTC)n 50-ﬂaps of the
Okazaki fragments may form a stable triplex61 with the
downstream repetitive run. This could block displacement
synthesis by the lagging strand polymerase62 and prompt it to
search for a new template. Large-scale repeat expansions would
then occur when the polymerase switches template—continuing
DNA synthesis along the nascent leading strand. As a starting
repeat gets longer, larger expansions become feasible, consistent
with the progressive increase in expansion amplitudes with the
length of original repeat tract, as observed in human pedigrees63.
The profound stimulation of large-scale expansions in the
phosphate steering mutants unexpectedly sheds light on the
molecular mechanism of template switching. A priori, either a
nascent leading strand can switch onto the nascent lagging strand
to use it as a template49,50, or the nascent lagging strand can
switch onto the nascent leading strand serving as a template47.
Since it is the lagging strand synthesis and speciﬁcally Okazaki
fragment maturation that are unraveled in Rad27 mutants, the
sheer magnitude of their effects on large-scale repeat expansions
implies that the lagging strand likely switches onto the nascent
leading strand accounting for the repeat instability, and this
merits further biochemical investigation. Another question
emerges from biochemical studies of FEN1 functions during
long-patch base excision repair where expansions occur on
dysregulation of DNA handoffs from polymerase b to FEN1 (ref.
64), which suggests studies to investigate whether phosphate
steering may prevent expansions during long-patch repair.
In summary, we ﬁnd FEN1 phosphate steering energetically
promotes dsDNA rotation into the active site and inverted
threading of the 50-ﬂap to enforce efﬁciency and ﬁdelity in
replication and repair. Interestingly, elevated FEN1 expression
safeguards against repeat instability in somatic tissues6.
Phosphate steering mutations could thus be the trans-modiﬁers
of repeat expansions during either somatic, or intergenerational
transmissions in human disease65. Moreover, as the basic residues
implicated in phosphate steering are largely conserved in the
50-nuclease superfamily, control over the þ 1 and  1
phosphates may be a superfamily-conserved mechanism.
Methods
Site-directed mutagenesis. Plasmids for expression of mutant proteins were
prepared from either the pET29b-hFEN1D336(wt) or pET28b-hFEN1-(His)6
constructs, as indicated above, following the protocol outlined in the QuikChange
site-directed mutagenesis kit (Agilent Technologies, Inc.). Mutagenic primers were
purchased from Fisher Scientiﬁc, with desalting, then reconstituted in ultrapure
water and used as supplied. Mutagenic primer sequences were as follows: D86N,
50-ggcggcttgccattaaagacatacacgggctt-30 and 50-aagcccgtgtatgtctttaatggcaagccgcc-30 ;
R103A, 50-caaacgcagtgaggcgcgggctgaggca-30 and 50-tgcctcagcccgcgcctcactgcgtttg-30 ;
R103E, 50-ccaaacgcagtgaggagcgggctgaggcag-30 and 50-ctgcctcagcccgctcctcactgcgtt
tgg-30; R104A, 50-ctctgcctcagccgcccgctcactgcgt-30 and 50-acgcagtgagcgggcggctgaggc
agag-30; R104E, 50-acgcagtgagcgggaggctgaggcagag-30 and 50-ctctgcctcagcctcccgctcac
tgcgt-30 ; R129A, 50-ttagtgaccttcaccagcgccttagtgaatttttccacctc-30 and 50-gaggtggaaaaa
ttcactaaggcgctggtgaaggtcactaa-30; R129E, 50-ttagtgaccttcaccagctccttagtgaatttttccac
ctc-30 and 50-gaggtggaaaaattcactaaggagctggtgaaggtcactaa-30 ; K132A, 50-cactaagcgg
ctggtggcggtcactaagcagcac-30 and 50-gtgctgcttagtgaccgccaccagccgcttagtg-30 ; K132E,
50-gctgcttagtgacctccaccagccgcttagt-30 and 50-actaagcggctggtggaggtcactaagcagc-30;
R103ER104E, 50-gcttctctgcctcagcctcctcctcactgcgtttggcca-30 and 50-tggccaaacgcagtga
ggaggaggctgaggcagagaagc-30 ; R129EK132E, 50-gtgctgcttagtgacctccaccagctccttagtgaa
tttttccacc-30 and 50-ggtggaaaaattcactaaggagctggtggaggtcactaagcagcac-30 .
Protein expression. Plasmids encoding R100AD336 and D233ND336 human
FEN1 for crystallography were generated by site-directed mutagenesis from the
pET29b-hFEN1D336(wt) construct bearing a PreScission protease site and
(His)6-tag after residue 336 of the wt sequence21. Full length wt hFEN1 was
encoded using the pET28b-hFEN1-(His)6 vector reported previously12, and all
reported mutants were generated from this by site-directed mutagenesis. Proteins
were expressed in Rosetta (DE3)pLysS competent cells grown in 2YT media or
Terriﬁc Broth to an OD600 of 0.6–0.8 at 37 C then induced by addition of 1mM
IPTG, followed by incubation at 18 C for 18–24 h. Cells were collected by
centrifugation at 6,000 g/4 C, washed with PBS, then resuspended in buffer IMAC-
A1 (20mM Tris pH 7.0, 1.0M NaCl, 5mM imidazole, 0.02% NaN3, 5mM
b-mercaptoethanol supplemented with SIGMAFAST protease inhibitor tablets and
1mgml 1 chicken egg white lysozyme). Each suspension was kept on ice for 2 h
then stored frozen at  20 C until further processing, as detailed below.
Puriﬁcation of hFEN1 D86ND336 and R100AD336 and D233ND336. All steps
were carried out at 4 C. Chromatography was on an A¨KTA system with ﬂow rate
of 5.0mlmin 1 unless stated otherwise. Columns were from GE Healthcare,
unless stated otherwise. Frozen lysates were thawed on ice and homogenized by
sonication. Next, 0.1 volume of a 10% v/v TWEEN 20 solution was added. The
mixture was clariﬁed by centrifugation at 30,000 g for 30min. Supernatant was
loaded onto a Ni-IDA afﬁnity column, which was then washed with 5 column
volumes (CV) of buffer IMAC-A1, 5 CV of buffer IMAC-A2 (20mM Tris pH 7.0,
0.5M NaCl, 40mM imidazole, 0.02% NaN3, 0.1% v/v TWEEN 20, 5mM
b-mercaptoethanol). FEN1 was eluted with 5 CV of buffer IMAC-B1 (250mM
imidazole pH 7.2, 0.5M NaCl, 0.02% NaN3, 5mM b-mercaptoethanol). Pooled
fractions were diluted 1:5 with water and then loaded onto a HiPrep Heparin FF
16/10 column. The column was washed with 5 CV buffer HEP-A1 (25mM Tris
pH 7.5, 1mM CaCl2, 0.02% NaN3, 20mM b-mercaptoethanol). FEN1 was eluted
with a linear gradient of 100% HEP-A1 to 100% HEP-A2 (25mM Tris pH 7.5,
1mM CaCl2, 1.0M NaCl, 0.02% NaN3, 20mM b-mercaptoethanol) in 20 CV.
Pooled FEN1 fractions were diluted by slow addition of two volumes of 3.0M
(NH4)2SO4 at 4 C. The solution was loaded onto a HiPrep Phenyl FF (high sub)
16/10 phenylsepharose column. The column was washed with 7 CV buffer P/S-B1
(25mM Tris pH 7.5, 2.0M (NH4)2SO4, 2mM CaCl2, 0.02% NaN3, 20mM
b-mercaptoethanol). FEN1 was eluted with a gradient of 100% P/S-B1 to 100%
P/S-A1 (25mM Tris pH 7.5, 10% v/v glycerol, 1mM CaCl2, 0.02% NaN3, 20mM
b-mercaptoethanol) in 20 CV. Pooled fractions were concentrated toB7ml using
an Amicon stirred cell (Merck Millipore), then passed through 5 5ml HiTrap
Desalting columns arranged in tandem, injected in 1.5ml portions. The desalting
columns were equilibrated in 1TBS supplemented with 1mM EDTA and 1mM
DTT, and eluted with the same buffer. Combined protein-containing eluent
(35–40ml) was treated with PreScission protease (20 ml of activity 10U ml 1) and
incubated at 4 C overnight. Complete cleavage of the (His)6 tag was veriﬁed by
SDS-PAGE, then the protein solution concentrated to 5ml using a Vivaspin
20 Centrifugal Concentrator (10,000 MWCO). A ﬁnal puriﬁcation step at a
0.5mlmin 1 ﬂow rate with a Sephacryl S-100 HR column, equilibrated with 2 CV
of 2 SB (100mM HEPES pH 7.5, 200mM KCl, 2mM CaCl2, 10mM DTT, 0.04%
NaN3). FEN1 fractions were pooled and the protein concentration determined by
A280, using the calculated OD280. The solution was concentrated to4200 mM using
a Vivaspin 20 Centrifugal Concentrator (10,000 MWCO). Finally, the solution was
mixed 1:1 v/v with cold glycerol, placed on a roller mixer until homogenous,
then divided into 1ml aliquots and stored as a 100 mM stock solution at  20 C.
Crystallography of mutant FEN1-DNA complexes. hFEN1 mutants were
crystallized with DF substrates (S5,1) or (S4,1) of slightly different sequence
(desalted purity from IDT, Supplementary Fig. 1). hFEN1-D86ND336
(19mgml 1) was mixed in volumetric ratio 1:2:1 with 4.25mM SmSO4,
and 1.3mM substrate S5,1-D86N. This mixture was in turn combined 1:1 with 12%
mPEG 2,000, 20% saturated KCl, 5% ethylene glycol, 100mM HEPES pH 7.5.
Crystals were collected after 5 days at 15 C. hFEN1-R100AD336 (19mgml 1)
was mixed in volumetric ratio 1:2:1 with 3.75mM SmSO4, and 1.3mM substrate
S4,1-R100A. This mixture was in turn combined 1:1 with 22% mPEG 2000, 20%
saturated KCl, 5% ethylene glycol, 100mM HEPES pH 7.5. Crystals were collected
afterB3 weeks at 15 C. hFEN1-D233ND336 (8.2mgml 1) with 1.6mM SmSO4,
0.25mM substrate S4,1-D233N was mixed 1:1 with 24% mPEG 2000, 20% satu-
rated KCl, 5% ethylene glycol, 100mM HEPES pH 7.5. hFEN1-D86N data was
collected at 0.98 Å (SSRL beamline 12-2) and processed with HKL2000. hFEN1-
R100A data was collected at 0.98 Å (SSRL beamline 9-2) and processed with XDS.
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hFEN1-D233N data was collected at 1.12Å (ALS beamline 12.3.1) and processed
with HKL2000. hFEN1-D86N, hFEN1-R100 and hFEN1-D233N crystals diffracted
to 2.8, 2.65 and 2.1 Å, respectively. Structures were solved by molecular replace-
ment using PHASER66 with human FEN1 protein as the search model and reﬁned
in PHENIX67 with rounds of manual rebuilding in COOT68. For hFEN1-R100A,
we reﬁned the model using higher diffraction data to 2.1 Å, based on the theory
that cutting off resolution at an arbitrary point leads to series termination errors.
Flexible regions became more visible and we could follow the path of the 50-ﬂap
more easily. The R and Rfree measures dropped substantially. We used a higher
resolution structure (PDB code: 3Q8K) for reference in reﬁnement. For the three
structures, anomalous differences from the Sm3þ atoms were used in reﬁnement
and modelling. In the active sites of the hFEN1-D86N, hFEN1-R100A and hFEN1-
D233N structures there were, respectively, one, three and four Sm3þ atoms, with
partial occupancy. For all structures, there were no Ramachandran outliers. For
hFEN1-D86n, 95% were favoured and 5% were allowed. For hFEN1-R100A, 96%
were favoured and 4% were allowed. For hFEN1-D233N, 98% were favoured and
2% were allowed. Structure ﬁgures were created in PyMol (Schro¨dinger, LLC).
Movies were created in Chimera69.
Protein puriﬁcation of full-length FEN1 proteins. All steps were carried out
using an A¨KTA FPLC system at 4 C, at a ﬂow rate of 5.0mlmin 1 unless stated
otherwise. Frozen/thawed lysates were loaded onto a Ni-IDA column, followed by
washing with 4 CV buffer IMAC-A1, 4 CV buffer IMAC-A2, a gradient of 100%
IMAC-A2 to 100% IMAC-B1 in 2 CV, then 4 CV IMAC-B1. Pooled fractions were
diluted 1:1 with 20mM b-mercaptoethanol and loaded onto a 5ml HiTrap Q FF
column to remove nucleic acid contamination, with a 20 CV elution gradient from
0 to 1.0M NaCl in 20mM Tris pH 8.0, 1mM EDTA, 0.02% NaN3, 20mM
b-mercaptoethanol. The ﬂow-through containing FEN1 was diluted 1:4 with
20mM b-mercaptoethanol and passed through the HiPrep Heparin FF 16/10
column as above. The puriﬁed FEN1 was exchanged into 2 SB using a HiPrep
26/10 Desalting column, concentrated and prepared for storage as detailed above.
Proteins requiring further puriﬁcation (wt hFEN1 and D233N) were passed
through the HiPrep Phenyl FF (high sub) 16/10 phenylsepharose column, as above.
Protein-containing fractions were pooled and concentrated to 5ml using an
Amicon stirred cell, subjected to gel ﬁltration and prepared for storage as
outlined above.
Oligonucleotide synthesis. The DNA oligonucleotides used for crystallization
(Supplementary Fig. 1) were purchased from IDT as desalted oligonucleotides.
They were resuspended in 10mM HEPES 7.5, 50mM KCl, 0.5mM EDTA and
annealed at B1–2mM. The DNA oligonucleotides used to construct the kinetic
substrates (Supplementary Fig. 1) were purchased from DNA Technology A/S
(Denmark) with HPLC puriﬁcation. Except for E1 and E2 (Supplementary
Fig. 1A), the oligonucleotides as supplied were reconstituted in ultrapure water
and concentrations of stock solutions determined using calculated extinction
coefﬁcients (OD260). Oligonucleotides E1 and E2 required additional HPLC
puriﬁcation, which was carried out using an OligoSep GC cartridge (Transgenomic;
#NUC-99–3860) using buffers A (100mM triethylammonium acetate pH 7.0,
0.025% v/v acetonitrile) and B (100mM triethylammonium acetate pH 7.0, 25%
acetonitrile) and a gradient of 5–50% B over 18min, at 50 C and a ﬂow rate of
1.5mlmin 1. Puriﬁed oligonucleotide in solution was loaded onto a 5ml HiTrap
DEAE FF column equilibrated with 3 CV of buffer C (10mM Tris pH 7.5, 100mM
NaCl, 1mM EDTA, 0.02% NaN3). The column was washed with a further 3 CV of
buffer C, then eluted using a step gradient of 100% buffer C-100% buffer D (10mM
Tris pH 7.5, 1.0M NaCl, 1mM EDTA, 0.02% NaN3) in 3 CV. Fractions containing
DNA were desalted into ultrapure water using NAP-25 columns. Desalted samples
were dried then reconstituted as above. DNA constructs were annealed in 1 FB
(50mM HEPES pH 7.5, 100mM KCl) for at least 5min at 95 C, then left at
ambient temperature for 30min.
FRET binding assay. Values for Kd were obtained using sequential titration of the
appropriate enzyme into a 10 nM solution of the appropriate DNA construct,
according to the reported protocol44. FRET efﬁciencies (E) were determined using
the (ratio)A method by measuring the enhanced acceptor ﬂuorescence at 37 C.
The steady state ﬂuorescent spectra of 10 nM non-labelled (NL) trimolecular,
donor-only labelled (DOL) and doubly labelled (DAL) DNA substrates
(Supplementary Fig. 1A,B) were recorded using a Horiba Jobin Yvon FluoroMax-3
ﬂuorometer. For direct excitation of the donor (ﬂuorescein, DOL) or acceptor
(TAMRA, AOL), the sample was excited at 490 nm or 560 nm (2 nm slit width) and
the emission signal collected from 515–650 nm or 575–650 nm (5 nm slit width).
Emission spectra were corrected for buffer and enzyme background signal by
subtracting the signal from the NL DNA sample. In addition to 10 nM of the
appropriate DNA construct, samples contained 10mM CaCl2 or 2mM EDTA,
110mM KCl, 55mM HEPES pH 7.5, 0.1mgml 1 bovine serum albumin and
1mM DTT. The ﬁrst measurement was taken before the addition of protein with
subsequent readings taken on the cumulative addition of the appropriate enzyme in
the same buffer, with corrections made for dilution. Transfer efﬁciencies (E) were
determined according to equation (1), where FDA and FD represent the ﬂuorescent
signal of the DAL and DOL DNA at the given wavelengths, respectively (for
example, FDA(lDEX, lAEM), denotes the measured ﬂuorescence of acceptor
emission on excitation of the donor, for DAL DNA); eD and eA are the molar
absorption coefﬁcients of donor and acceptor at the given wavelengths; and
eD(490)/eA(560) and eA(490)/eA(560) are determined experimentally from the
absorbance spectra of DAL and the excitation spectra of singly TAMRA-AOL,
respectively. Energy transfer efﬁciency (E) was ﬁtted by non-linear regression in the
Kaleidagraph program to equation (2), where Emax and Emin are the maximum and
minimum energy transfer values, [S] is the substrate concentration, [P] is the
protein concentration and Kbend is the bending equilibrium dissociation constant of
the protein substrate [PS] complex.
E ¼ ratioð ÞA=
eD 490ð Þ
eA 560ð Þ
 
 e
A 490ð Þ
eA 560ð Þ
 
; ð1Þ
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Donor (ﬂuorescein) was excited at 490 nm with emission sampled as the
average value of the signal between 515 and 525 nm, and acceptor (TAMRA) was
excited at 560 nm with emission averaged between 580 and 590 nm.
Multiple turnover rates. Reaction mixtures (ﬁnal volume 180ml) were prepared
in 1.5ml microcentrifuge tubes with 50 nM ﬁnal substrate concentration (S5,1;
S0,1-5P; S0,1-5OH; or S0,1-5FAM) and incubated at 37 C before addition of
enzyme to initiate the reaction. The ﬁnal composition of each reaction mixture was
1RB (55mM HEPES pH 7.5, 110mM KCl, 8mM MgCl2, 0.1mgml 1 BSA)
supplemented with 1mM DTT. Enzyme concentrations were chosen to giveB15%
cleavage after 20min, and any data points showing greater cleavage were discarded
due to effects of substrate depletion. For substrates S5,1 and S0,1-5FAM, aliquots
(20 ml) of each reaction mixture were quenched into 250mM EDTA (50 ml) at
seven different time points—typically 2, 4, 6, 8, 10, 12 and 20min—and reaction
progress monitored by dHPLC analysis using a WAVE system equipped with an
OligoSep cartridge (4.6 50mm; ADS Biotec). The 6-FAM label was detected by
ﬂuorescence (excitation 494 nm, emission 525 nm) and product(s) separated from
unreacted substrate using the following gradient: 5–30% B over 1min; 30–55% B
over 4.5min; 55–100% B over 1.5min; 100% B for 1.4min; ramp back to 5% B over
0.1min; hold at 5% B for 2.4min, where A is 0.1% v/v MeCN, 1mM EDTA,
2.5mM tetrabutylammonium bromide and B is 70% v/v MeCN, 1mM EDTA,
2.5mM tetrabutylammonium bromide12. Initial rates (v, nMmin 1) were
determined by linear regression of plots of product concentration versus time and
adjusted for enzyme concentration to give normalized rates (v/[E], min 1). For
analysis of exonucleolytic activity, reactions with substrates S0,1-5P and S0,1-5OH
were run as above but quenched in 98% deionised formamide containing 10mM
EDTA. Time points and enzyme concentrations were selected to give 10–15%
cleavage at the reaction end point (Z20min). The quenched samples were
analysed by capillary electrophoresis as detailed below, then rates determined and
normalized as above.
Analysis of reaction aliquots by capillary electrophoresis. Capillary electro-
phoresis was performed with the P/ACE MDQ Plus system (Beckman Coultier)
using the ssDNA 100-R Kit (AB SciEx UK Limited; #477480) according to the
manufacturer’s instructions. Brieﬂy, the supplied capillary (ID 100 mm, 30 cm long;
20 cm to detection window) was loaded with the commercially supplied gel using
70 psi of pressure for 5min. The capillary was then equilibrated between two buffer
vials containing Tris-Borate-Urea buffer (AB SciEx UK Limited; #338481) at 3,
5 and 9.3 kV for 2, 2 and 10min, respectively, with a ramp time of 0.17min.
Samples were then run using a 5 s electrokinetic injection preceded by a 1 s plug
injection of deionised water, before separation over 20min with a voltage of 9.3 kV
applied between two buffer vials; runs were carried out at 50 C with constant
pressure of 40 psi maintained on both sides of the capillary. The gel was replaced
every ﬁve sample runs and running buffer was replaced every 20 sample runs. Peak
detection was by laser induced ﬂuorescence (LIF) using an excitation wavelength of
488 nm and a 520 nm ﬁlter to measure the emission. The electrophoretograms were
integrated to determine the concentration of product formed at each time point.
Initial rates of reaction (v, nMmin 1) were then obtained using linear regression,
and converted to the reported normalized rates (v/[E], min 1) as above.
Single turnover rapid quench experiments. Rapid quench experiments for
determination of single turnover rate were carried out for wt hFEN1 and the
mutants R104A, K132A, R103AR129A and D233N. Reactions were carried out at
37 C using an RQF-63 device (HiTech Limited, Salisbury, UK)12,70. Premix stock
solutions of enzyme and substrate were prepared at 2 ﬁnal concentration in
reaction buffer (55mM HEPES pH 7.5, 110mM KCl, 8mM MgCl2, 2.5mM DTT
and 0.1mgml 1 BSA) and kept on ice until use. For individual reactions, the two
80 ml sample injection loops of the instrument (lines A and B) were ﬁlled with
aliquots of enzyme and substrate stock, respectively. The syringe feeding the
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quench line contained 1.5M NaOH, 20mM EDTA. Individual reactions were
carried out using a controlled time delay of between 0.0091 and 51.241 s before
quenching, with ﬁnal concentrations of 5 nM substrate S5,1 and either 400 nM
or 1,000 nM enzyme, as indicated (Supplementary Fig. 4C,D). Quenched reaction
mixtures were analysed by dHPLC as described above for multiple turnover
reactions, and rates were derived from curves consisting of at least 14 individual
time points. The single turnover rate of the reaction was obtained as the ﬁrst-order
rate constant (kST) derived using nonlinear least squares regression for a one- or
two-phase exponential in GraphPad Prism 6.05 (GraphPad Software, Inc.). Model
selection was by statistical analysis using Aikake’s Information Criteria (AIC).
Benchtop single turnover experiments. For the remaining proteins—hFEN1
mutants R104AK132A, R103ER129E, R104EK132E, QUAD-E (R103E/R104E/
R129E/K132E) and D181A—reactions to determine single turnover rates were
carried out using manual sampling, as described for the multiple turnover reactions
above, except using 5 nM substrate S5,1 and an enzyme concentration of either
400 nM or 1,000 nM as indicated in each case (Supplementary Fig. 4C,D). A ﬁnal
reaction volume of 360ml was used, permitting sampling of 14 time points per tube,
which were typically chosen to span a reaction duration of at least 20 half-times.
Quenched samples were analysed by dHPLC as detailed above, then single turnover
rates were derived as described for the rapid quench experiments.
Yeast strain construction. To construct the individual yeast mutants, the
hphMX4 hygromycin resistance marker was ﬁrst integrated downstream of Rad27,
replacing genomic region ChrXI:224,681–224,712, in a strain containing the
Ura3-(GAA)100 cassette49 derived from parent strain CH1585 (MATa leu2-D1,
trp1-D63, ura3–52, and his3–200). The rate of (GAA)100 expansion in this strain
(designated Rad27-Hyg) was indistinguishable from the wild type strain not
carrying the downstream hphMX4 cassette. Genomic DNA from Rad27-Hyg was
used as a template for PCR with aB100 bp forward primer containing the speciﬁc
mutations and a reverse primer downstream of the hphMX4 cassette. These
PCR products were used to transform the wt (GAA)100 strain with selection on
200mgml 1 hygromycin. Transformants were screened by PCR and/or restriction
digest, and the full-length sequences of the mutated Rad27 alleles were veriﬁed by
Sanger sequencing. The length of the starting (GAA)100 tract in the mutant strains
was conﬁrmed by PCR using primers A2 (50-CTCGATGTGCAGAACCTGAAGC
TTGATCT-30) and B2 (50-GCTCGAGTGCAGACCTCAAATTCGATGA-30).
Yeast spot assay. Fivefold serial dilutions were made on an equivalent starting
number of cells for each strain. A 2.5 ml aliquot of each dilution was spotted onto
YPD, YPD with 10mgml 1 camptothecin, or YPD with 100mM hydroxyurea. For
UV treatment, cells spotted onto YPD were immediately irradiated using a UV
Stratalinker 1,800 (Stratagene).
Fluctuation assay and expansion rates. At least two independent isolates of each
yeast mutant were diluted from frozen stocks and grown for 40 h on solid rich
growth media (YPD) supplemented with uracil. 16 individual colonies (8 per
isolate) were dissolved in 200ml of water and serially diluted. Appropriate dilutions
were plated on synthetic complete media containing 0.09% 5-ﬂuoro-orotic acid
(5FOA) to select for large-scale expansion events or YPD to assess total cell
number. Colonies on each plate were counted after three days of growth. For each
mutant, at least 96 representative 5FOA colonies (8–12 per plate) were analysed for
large-scale GAA expansion via PCR using primers A2 and B2 followed by agarose
gel electrophoresis (1.5% agarose in 0.5X TBE). To determine a true expansion rate
(as opposed to a gene inactivation rate), the number of 5FOA-r colonies counted
per plate was adjusted by the overall percentage of GAA expansion events observed
for that mutant. Expansion rates were calculated using the Ma-Sandri-Sarkar
maximum likelihood estimator method with a correction for plating efﬁciency
determined as z-1/zln(z), where z is the fraction of the culture analysed (Rosche
and Foster, 2000). PCR product lengths for the calculation of GAA expansion size
were determined using cubic spline interpolation on Total Lab Quant software.
Kolmogorov-Smirnov comparison of expansion lengths between strains was
conducted using SPSS software—non-parametric testing of independent samples.
Genotype information for each strain used is shown in Supplementary Table 1.
Extraction of Rad27 proteins and western blotting. Wt and mutant strains in
mid-log phase (OD600 0.6–0.8, 10mls) were pelleted, washed with water and
frozen. Pellets were resuspended in 150 ml of distilled water, mixed with an equal
volume of 0.6M NaOH with a 10min incubation at room temperature. After low
speed centrifugation (153 g) for 5min, the supernatant was removed and each
pellet resuspended in SDS sample loading buffer (60mM Tris-HCl pH 6.8, 4%
b-mercaptoethanol, 4% SDS, 0.01% bromophenol blue, 5% glycerol). The samples
were boiled for 3min, then 10ml of each separated by 4–12% SDS–PAGE gel
(Invitrogen) followed by Western blotting using anti-RAD27 goat polyclonal
antibody (1:125 dilution; Santa Cruz Biotechnology, #sc-26719), donkey anti-goat
IgG-HRP secondary antibody (1:2,500; Santa Cruz Biotechnology; #sc-2020) and
visualized using an ECL detection kit (GE Healthcare). A nonspeciﬁc band present
in all lanes was used as a loading control (Fig. 5d).
Data availability. Coordinates and structure factors are deposited with the Protein
Data Bank (PDB) under the accession codes: 5UM9 (D86N), 5KSE (R100A), and
5K97 (D233N). The data that support the ﬁndings of this study are available from
the corresponding authors on request.
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